BioXcel Therapeutics (BTAI) Gross Margin Growth (3y) (2025 - 2026)
BioXcel Therapeutics (BTAI) Gross Margin Growth (3y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | 567.00 |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | -100.00 |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | -196.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -228.00 |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 12.00 |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | -61.00 |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.42 Mn | 24.42 Mn | 160,000.00 | -640.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -640.00 |
| Mar 31, 2026 | -13,301.00 |
| Dec 31, 2025 | -872.00 |
| Sep 30, 2025 | -320.00 |